A unit of China Resources Pharmaceutical Group (HKG:3320) obtained a registration acceptance notice for the proposed issue of medium-term bonds from the National Association of Financial Market Institutional Investors, according to a May 29 Hong Kong bourse filing.
Shares of the pharmaceutical firm were up over 2% in Monday afternoon trading.
The acceptance will allow unit China Resources Pharmaceutical Holdings to issue up to 5 billion yuan of bonds in various tranches within two years.
Proceeds from the issue are expected to be used to replenish working capital and repay debt among other uses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments